Nasdaq: SMMT

Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker SMMT. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
SMMT
Exchange
Nasdaq
SEC CIK
1599298
Official filings
SEC EDGAR

Research SMMT

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Summit Therapeutics Inc.'s stock ticker?

Summit Therapeutics Inc. trades under the ticker symbol SMMT on Nasdaq. Its SEC Central Index Key (CIK) is 1599298.

Where can I read Summit Therapeutics Inc.'s SEC filings?

The SMMT SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Summit Therapeutics Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze SMMT's financial statements?

The SMMT Financials page shows Summit Therapeutics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does SMMT compare with its peers and the market?

The SMMT Peer Comparison page lines Summit Therapeutics Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.